Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 12 2020
Historique:
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 28 4 2021
Statut: ppublish

Résumé

Enteric fever remains a public health concern in communities lacking sanitation infrastructure to separate sewage from drinking water. To bridge the gap until large-scale civil-engineering projects are implemented in high-burden countries, typhoid conjugate vaccine presents a promising disease-prevention technology. A new typhoid conjugate vaccine was prequalified by the World Health Organization in 2017 and is beginning to be introduced in countries around the world. To help inform vaccine introduction, the Surveillance for Enteric Fever in Asia Project (SEAP) conducts prospective enteric fever surveillance in Bangladesh, Nepal, and Pakistan. This supplement presents findings from Phase II of the study (2016-2019) on burden of disease, clinical presentation, the growing spread of drug-resistant strains, and policy and economic ramifications. These findings are delivered to support policymakers in their deliberations on strategies to introduce typhoid conjugate vaccine as a preventive tool against enteric fever.

Identifiants

pubmed: 33258930
pii: 6013557
doi: 10.1093/cid/ciaa1296
pmc: PMC7705880
doi:

Substances chimiques

Typhoid-Paratyphoid Vaccines 0
Vaccines, Conjugate 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S191-S195

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

J Infect Dis. 2018 Nov 10;218(suppl_4):S188-S194
pubmed: 30304505
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S165-S170
pubmed: 30845331
Curr Opin Gastroenterol. 2018 Jan;34(1):25-30
pubmed: 29059070
Clin Infect Dis. 2019 Mar 5;68(6):949-955
pubmed: 30020426
J Infect Dis. 2018 Nov 10;218(suppl_4):S268-S276
pubmed: 30184162
Bull World Health Organ. 2008 Apr;86(4):260-8
pubmed: 18438514
Vaccine. 2015 Jun 19;33 Suppl 3:C3-7
pubmed: 25912287
J R Soc Interface. 2008 Jan 6;5(18):3-13
pubmed: 17459810

Auteurs

Alice S Carter (AS)

Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.

Stephen P Luby (SP)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.

Denise O Garrett (DO)

Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH